NicOx SA (COX) to Release Q4 2007 Earnings March 3

NicOx SA (EPA:COX) will release the fourth quarter earnings for 2007 on March 3.

Based in France, NicOx is a pharmaceutical research company that specializes in the design and development of safer and more effective drugs using the recently discovered properties of nitric oxide.  The company is engaged in the development of nitric oxide-donating drugs in two therapeutic areas, inflammation and cardiovascular diseases.

The company product line includes Naproxcinod, NCX 4016 and NCX 6560.

The company operates a research institute in Bresso, Italy.

NicOx has co-development agreements with Axcam Pharma Inc, Biolipox AB and Topigen Pharmaceuticals Inc as well as research alliances with Merk and Co Inc, Pfizer Inc (NYSE:PFE) and Grupo Ferrer International SA.

For more Earnings related events or to post your own events, visit:

http://events.finditt.com/Events_list.aspx?catid=13